MENU

Fox Chase Cancer Center Welcomes J. Nicholas Bodor

July 14, 2020

PHILADELPHIA (July 14, 2020) – Fox Chase Cancer Center announces the hiring of J. Nicholas Bodor, MD, PhD, MPH, who will join the Department of Hematology/Oncology and serve in the Thoracic Oncology Program. Bodor will be joining Fox Chase upon completion of the Fox Chase-Temple Hematology/Oncology Fellowship Program.

He received his medical degree from the Louisiana State University School of Medicine in New Orleans. Bodor also earned a doctorate in Public Health Nutrition and a master of public health degree with a concentration in maternal and child health and epidemiology from the Tulane University School of Public Health and Tropical Medicine. He completed his residency training in internal medicine at the University of Maryland Medical Center.

Bodor is board certified in internal medicine. He is a member of the American Society of Clinical Oncology, Eastern Cooperative Oncology Group, and the International Association for the Study of Lung Cancer.

Bodor has been published in several public health and medical oncology peer-reviewed journals. He has also made multiple conference presentations in both public health and medical oncology. He is a recipient of a 2018 ASCO Annual Meeting Merit Award.

Bodor will begin work at Fox Chase on August 1, 2020.

      

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

 

For more information, call 888-369-2427

Connect with Fox Chase